Details of the Drug Reposition

General Information of This Drug (ID: DMBLASN)

Drug Name
DCVax-Ovarian   DMBLASN
Synonyms DCVax-L; Dendritic cell-based immunotherapy (ovarian cancer), Northwest Biotherapeutics

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Brain cancer DISBKFB7 2A00 Phase 3 [1]
Pain DIS4RWOW MG30-MG3Z Phase 3 [2]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ovarian cancer DISZJHAP 2C73 Phase 1 [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT00045968) Study of a Drug [DCVax-L] to Treat Newly Diagnosed GBM Brain Cancer. U.S. National Institutes of Health.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)